Literature DB >> 19410329

Molecular analysis of the HuD gene in neuroendocrine lung cancers.

Vito D'Alessandro1, Lucia Anna Muscarella, Annamaria la Torre, Michele Bisceglia, Paola Parrella, Gerardo Scaramuzzi, Clelia Tiziana Storlazzi, Domenico Trombetta, Klaas Kok, Angelo De Cata, Marco Sperandeo, Leopoldo Zelante, Massimo Carella, Gianluigi Vendemiale.   

Abstract

n-ELAV (neuronal-Embryonic Lethal, Abnormal Vision)-like genes belong to a family codifying for onconeural RNA-binding proteins, also called Hu antigens. Anti-Hu-antibodies (anti-Hu-Ab) are typically associated with paraneoplastic encephalomyelitis/sensory neuropathy (PEM/PSN), and low titres of anti-Hu-Ab were found in neural/neuroendocrine neoplasms, especially small cell lung cancer (SCLC). To date, few studies have been published focused on the genetic causes of their involvement in the pathogenesis of neuroendocrine tumors (NE). Here we analyzed 20 primary human neuroendocrine lung tumor tissues for somatic mutations in the HuD gene. Two inactivating mutations (a frameshift and a stop codon mutation) and 11 nucleotide changes were detected in the coding sequence of HuD gene in 7 different lung tumors. Our results on SCLC and carcinoid tissues support the hypothesis that alterations of nELAV genes could be involved in the onset and/or progression of a subset of neuroendocrine lung tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19410329     DOI: 10.1016/j.lungcan.2009.03.022

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  10 in total

Review 1.  The complex world of post-transcriptional mechanisms: is their deregulation a common link for diseases? Focus on ELAV-like RNA-binding proteins.

Authors:  Alessia Pascale; Stefano Govoni
Journal:  Cell Mol Life Sci       Date:  2011-09-10       Impact factor: 9.261

2.  Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4.

Authors:  Mario A Pulido; Meleeneh Kazarian DerHartunian; Zhenxia Qin; Eric M Chung; Diane S Kang; Andrew W Woodham; Jeffrey A Tsou; Rinse Klooster; Omid Akbari; Lina Wang; W Martin Kast; Stephen V Liu; Jan J G M Verschuuren; Dana W Aswad; Ite A Laird-Offringa
Journal:  J Neuroimmunol       Date:  2016-09-03       Impact factor: 3.478

Review 3.  RNA-Binding Protein HuD as a Versatile Factor in Neuronal and Non-Neuronal Systems.

Authors:  Myeongwoo Jung; Eun Kyung Lee
Journal:  Biology (Basel)       Date:  2021-04-23

4.  CDR2 antigen and Yo antibodies.

Authors:  Cecilie Totland; Nina K Aarskog; Tilo W Eichler; Mette Haugen; Jane K Nøstbakken; Sissel E Monstad; Helga B Salvesen; Sverre Mørk; Bjørn I Haukanes; Christian A Vedeler
Journal:  Cancer Immunol Immunother       Date:  2010-11-16       Impact factor: 6.968

Review 5.  Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.

Authors:  Meleeneh Kazarian; Ite A Laird-Offringa
Journal:  Mol Cancer       Date:  2011-03-30       Impact factor: 27.401

Review 6.  Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction.

Authors:  Lucas M Bronicki; Bernard J Jasmin
Journal:  RNA       Date:  2013-08       Impact factor: 4.942

Review 7.  Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies: A beneficial antitumor immune response going awry.

Authors:  Béatrice Sl Pignolet; Christina Mt Gebauer; Roland S Liblau
Journal:  Oncoimmunology       Date:  2013-12-10       Impact factor: 8.110

Review 8.  [Research advance on non-small cell lung carcinoma with neuroendocrine differentiation].

Authors:  Yun Dai; Baohui Han
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-02

9.  B-cell lymphoma gene regulatory networks: biological consistency among inference methods.

Authors:  Ricardo de Matos Simoes; Matthias Dehmer; Frank Emmert-Streib
Journal:  Front Genet       Date:  2013-12-16       Impact factor: 4.599

10.  Clinicopathological characteristics and genetic analysis of pulmonary carcinoid tumors: A single-center retrospective cohort study and literature review.

Authors:  Xiongfei Li; Yuelong Hou; Tao Shi; Yue He; Dian Ren; Zuoqing Song; Sen Wei; Gang Chen; Jun Chen; Song Xu
Journal:  Oncol Lett       Date:  2020-01-24       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.